April 30, 2021
Despite coming out on top of analysts’ revenue predictions, Dexcom’s stock is tumbling after the company shared its first quarter of 2021 financial results.
As of Friday afternoon, Dexcom’s stock has fallen 6.3% from about $422 to $395.
Still, the company posted year-over-year growth for Q1 and increased its expectations for the remainder of the year.
“Dexcom is off to a great start in 2021,...